Aptose Biosciences Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aptose Biosciences Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q4 2024.
  • Aptose Biosciences Inc. Debt-to-equity for the quarter ending December 31, 2024 was -385 %, a 412% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 -385 -509 -412% Dec 31, 2024
Q3 2024 -439 -500 -813% Sep 30, 2024
Q2 2024 1.93K +1.89K +4737% Jun 30, 2024
Q1 2024 290 +262 +941% Mar 31, 2024
Q4 2023 123 +104 +531% Dec 31, 2023
Q3 2023 61.6 +47 +323% Sep 30, 2023
Q2 2023 39.9 +28.1 +239% Jun 30, 2023
Q1 2023 27.8 +18 +182% Mar 31, 2023
Q4 2022 19.6 +11.3 +137% Dec 31, 2022
Q3 2022 14.5 +7.39 +103% Sep 30, 2022
Q2 2022 11.8 +5.8 +96.9% Jun 30, 2022
Q1 2022 9.85 +4.05 +69.8% Mar 31, 2022
Q4 2021 8.26 +2.27 +37.8% Dec 31, 2021
Q3 2021 7.15 +0.97 +15.7% Sep 30, 2021
Q2 2021 5.98 -2.01 -25.2% Jun 30, 2021
Q1 2021 5.8 -3 -34.1% Mar 31, 2021
Q4 2020 6 -5.91 -49.6% Dec 31, 2020
Q3 2020 6.18 -12.1 -66.1% Sep 30, 2020
Q2 2020 7.99 Jun 30, 2020
Q1 2020 8.8 Mar 31, 2020
Q4 2019 11.9 Dec 31, 2019
Q3 2019 18.3 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.